A carefully determined mixture of electron and x ray beams precisely treated breast tumors while significantly reducing collateral skin damage.
Ads by Google
Could contribute to inaccurate screening of breast cancer.
Tamoxifen as a breast cancer prevention drug has little impact on overall mortality rates for most "high risk" women.
Breast cancer positive treatment effects from the drug Tamoxifen are only experienced by women with a very high risk for the cancer.
The most aggressive form of breast cancer may originate from breast stem cells that have undergone genetic mishaps.
Study on breast cancer highlights options for women with breast implants.
Giving breast cancer patients fewer but larger doses of radiotherapy for treatment may be as safe and as effective at reducing the risk of cancer returning.
The risk of developing breast cancer is doubled in women who inherit a damaged version of a gene called ATM.
The vast majority of women students worldwide know nothing about the lifestyle habits that can influence breast cancer risk and symptoms.
A drug that targets a particular type of breast cancer might be more effective if patients are also given a substance made by the body that stimulates certain immune cells.
A method is twice as accurate at spotting breast cancer cells as a pathologist's view with a microscope.
Weight gain, particularly after menopause, is associated with an increased risk of breast cancer in women.
By treating male breast cancer with a combination of anastrozole and a synthetic hormone called goserelin physicians may be able to stop the transition of the male hormone testosterone to the estrogen estradiol.
A new therapy allows women diagnosed with breast cancer to reduce the time needed for radiation treatment.
This new finding not only predicts chemotherapy response in breast cancer before beginning of treatment, but it also permits to act upon (NF) ĸB, deactivate it and promote chemotherapy response.
Hormonal treatments reduce risk of breast cancer returning, finds 10 year study.
17% lower chance of dying and 25% lower risk of breast cancer recurrence in postmenopausal hormone sensitive patients switching to Aromasin rather than staying on Tamoxifen.
By performing a brief MR spectroscopy doctors can noninvasively see which tumors show elevated choline levels, a sign of breast tumor.
Adding breast MRI screening may be cost effective for women of certain ages who carry the BRCA1 and BRCA2 gene mutations.
Higher risk of breast cancer among postmenopausal women may be related to long term estrogen therapy.
Invasive lobular carcinoma of the breast can be treated with breast conserving surgery, as is invasive ductal carcinoma, without greater future risk of radical surgical treatment.
Follow up mammograms reliable for detecting return of breast cancer.
Many women's beliefs on personal risk of breast cancer and expectations about the performance of mammography are unrealistic.
The study identifies a biological basis for persistent fatigue in breast cancer survivors that is implemented by inflammation.
Fatigue that affects about third of breast cancer survivors might be alleviated by behavioral interventions such as tai chi and yoga.
A promising new technique to ensure complete tumor removal at breast cancer excision.
Researchers have developed a polymer based therapy for breast cancer that could serve as an artificial tissue filler after surgery and a clinically effective therapy.
Use of annual mammography among breast cancer survivors, who are at increased risk of a recurrence or a new malignancy in the other breast, dropped off after a few years.